Zobrazeno 1 - 10
of 23
pro vyhledávání: '"H. Belch"'
BACKGROUND: Elotuzumab plus lenalidomide and dexamethasone has shown improved progression-free and overall survival versus lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma. We aimed to assess these regimens in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::418814b244db6b2aeca1aa0a25decc0e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220220
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3220220
Publikováno v:
Transactions of the American Nuclear Society - Volume 123.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a940f5239cac925be88d0e364ab5a08a
https://doi.org/10.13182/t123-33117
https://doi.org/10.13182/t123-33117
Autor:
Robert Hill, Stefano Passerini, T. Sumner, Richard B. Vilim, Anton Moisseytsev, Acacia J. Brunett, James J. Sienicki, Walid Mohamed, H. Belch, Florent Heidet, E. Jin, S. Hayes, Christopher Grandy, E. Hoffman
Publikováno v:
Progress in Nuclear Energy. 108:465-473
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8fc96123857cd9fdd283cd3ae74fefe
https://doi.org/10.1016/j.pnucene.2018.06.008
https://doi.org/10.1016/j.pnucene.2018.06.008